LEVITT DANIEL J 4
4 · AQUINOX PHARMACEUTICALS, INC · Filed May 16, 2018
Insider Transaction Report
Form 4
LEVITT DANIEL J
Director
Transactions
- Sale
Common Stock
2018-05-14$12.67/sh−3,906$49,489→ 0 total - Exercise/Conversion
Common Stock
2018-05-14$10.56/sh+3,906$41,247→ 3,906 total - Exercise/Conversion
Stock Option (Right to Buy)
2018-05-14−3,906→ 0 totalExercise: $10.56Exp: 2018-07-01→ Common Stock (3,906 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.65 to $12.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set in this footnote.
- [F2]All the shares subject to the 3,906 share option were fully vested.